Related references
Note: Only part of the references are listed.The bromodomain containing protein BRD-9 orchestrates RAD51-RAD54 complex formation and regulates homologous recombination-mediated repair (vol 11, 2639, 2020)
Qin Zhou et al.
NATURE COMMUNICATIONS (2022)
Promelanogenic Effects by an Annurca Apple-Based Natural Formulation in Human Primary Melanocytes
Maria Grazia Ferraro et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2021)
Identification of potential tumour-associated carbonic anhydrase isozyme IX inhibitors: atom-based 3D-QSAR modelling, pharmacophore-based virtual screening and molecular docking studies
Avinash Kumar et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Water molecules in protein-ligand interfaces. Evaluation of software tools and SAR comparison
Eva Nittinger et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2019)
GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer
Samantha M. Bevill et al.
MOLECULAR CANCER RESEARCH (2019)
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition
Nunzio Del Gaudio et al.
CELL DEATH & DISEASE (2019)
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer
Marialuisa Piccolo et al.
SCIENTIFIC REPORTS (2019)
Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel-Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7
Vittoria Zoppi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
The human protein atlas: A spatial map of the human proteome
Peter J. Thul et al.
PROTEIN SCIENCE (2018)
Nanomolar-Potency 1,2,4-Triazoloquinoxaline Inhibitors of the Kidney Urea Transporter UT-A1
Sujin Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Bromodomain inhibitors and cancer therapy: From structures to applications
Montserrat Perez-Salvia et al.
EPIGENETICS (2017)
Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe
Philip G. Humphreys et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Discovery of novel [1,2,4]triazolo[4,3-a]quinoxaline aminophenyl derivatives as BET inhibitors for cancer treatment
Imran Ali et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition
Natalie H. Theodoulou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Inhibition of BET bromodomains alleviates inflammation in human RPE cells
M. Hytti et al.
BIOCHEMICAL PHARMACOLOGY (2016)
NMR Fragment Screening Hit Induces Plasticity of BRD7/9 Bromodomains
Na Wang et al.
CHEMBIOCHEM (2016)
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
Laetitia J. Martin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains
Terry D. Crawford et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
Anja F. Hohmann et al.
NATURE CHEMICAL BIOLOGY (2016)
Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia
Sarah Picaud et al.
SCIENCE ADVANCES (2016)
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNFMutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
Bhavatarini Vangamudi et al.
CANCER RESEARCH (2015)
9H-Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain
Sarah Picaud et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains
Duncan A. Hay et al.
MEDCHEMCOMM (2015)
[1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of Diverse Bromodomains
Oleg Fedorov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
WEB Services as Applications' Integration Tool: QikProp Case Study
Abdel Laoui et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery
Martin Philpott et al.
MOLECULAR BIOSYSTEMS (2011)
The Biology of Chromatin Remodeling Complexes
Cedric R. Clapier et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results
Steven L. Dixon et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)
PHASE: A novel approach to pharmacophore modeling and 3D database searching
Steven L. Dixon et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)